Treatment of Mesenteric Panniculitis
Corticosteroids are the first-line therapy for symptomatic mesenteric panniculitis, with surgical intervention reserved only for cases with severe complications or when medical therapy fails. 1
Clinical Overview
- Mesenteric panniculitis is a rare, benign, and chronic fibrosing inflammatory disease affecting the adipose tissue of the mesentery, primarily in the small intestine 2
- The specific etiology remains unknown, though it may be immune-mediated or potentially paraneoplastic 3
- Diagnosis is typically suggested by CT imaging and confirmed by surgical biopsies in equivocal cases 2, 4
Medical Management
First-Line Therapy
- Prednisone/corticosteroids show good clinical and radiological responses during follow-up and should be initiated first 4
- Dosing should be tailored based on symptom severity and patient characteristics 1
Second-Line Therapies
- Immunomodulatory agents such as azathioprine can be added when corticosteroid response is inadequate 4
- Colchicine has shown efficacy either alone or in combination with other therapies 4
- Thalidomide and low-dose naltrexone are the only agents that have been prospectively evaluated for mesenteric panniculitis 3
Supportive Care
- Pain management is essential and requires collaboration between pain specialists, palliative care teams, and gastroenterologists 1
- Early dietetic consultation is crucial to optimize nutritional status and prevent malnutrition 1
- Patients should be monitored for new or worsening GI symptoms which may indicate disease progression or development of complications 1
Surgical Management
- Surgery should be reserved for cases with:
- Laparoscopic approach is preferred in stable patients due to lower morbidity 5
- Resection of fibrotic tissue may offer symptomatic relief but carries risk of short bowel syndrome 1, 6
Treatment Algorithm
Initial presentation:
For mild to moderate symptoms:
For inadequate response to corticosteroids:
For severe symptoms or complications:
Monitoring and Follow-up
- Regular clinical assessment of symptoms 1
- Follow-up CT imaging to evaluate treatment response 4
- Vigilance for potential malignancy development, as mesenteric panniculitis may be associated with underlying cancer 1, 3
- Nutritional status monitoring and support 1
Clinical Pitfalls and Considerations
- Mesenteric panniculitis can mimic other conditions including malignancy, inflammatory bowel disease, and mesenteric ischemia 6
- Surgical intervention is not curative and should be avoided except for specific complications 3
- The condition may spontaneously regress in some patients, while others experience prolonged symptoms requiring long-term management 3
- Patients should be educated about warning signs requiring urgent medical attention (severe pain, vomiting, fever) 5